SCHEMBL4911233

SCHEMBL4911233

N#Cc1ncccc1Oc1ncc(Cl)cc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.38
FEN1 P39748 3/20 0.38
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
CCR2 P41597 2/20 0.37
CYP2C9 P11712 2/20 0.37
CCR4 P51679 1/20 0.37
CYP1A2 P05177 1/20 0.37
NR4A2 P43354 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
APEX1 P27695 1/20 0.35
G6PD P11413 1/20 0.35
KMT2A Q03164 3/20 0.34
MAPT P10636 1/20 0.34
CYP19A1 P11511 1/20 0.34
ALDH1A1 P00352 2/20 0.34
PLCG1 P19174 1/20 0.33
MEN1 O00255 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7523971 0.84 CCR2 (0.39) ALOX5APFEN1CYP3A4CYP2C19CCR2
SCHEMBL4909567 0.82 CYP3A4 (0.41) CYP3A4CYP2C19CCR2CYP2C9CCR4
SCHEMBL4910281 0.81 CCR2 (0.53) CYP3A4CYP2C19CCR2CYP2C9CCR4
SCHEMBL4910398 0.79 ALDH1A1 (0.49) CYP3A4CYP2C19CCR2CYP2C9CCR4
SCHEMBL14006333 0.76 CYP1A2 (0.49) CYP3A4CYP2C19CYP2C9CYP1A2SMN1; SMN2
SCHEMBL4910086 0.74 SLC6A4 (0.38) CYP3A4CYP2C19CCR2CYP2C9CCR4
SCHEMBL4902844 0.73 L3MBTL1 (0.43) CYP3A4CYP2C19CCR2CYP2C9CCR4
SCHEMBL305726 0.73 MEN1 (0.48) CYP3A4CYP2C19CCR2CYP2C9CYP1A2
SCHEMBL4912414 0.72 CYP2C9 (0.53) CYP3A4CYP2C19CCR2CYP2C9CYP1A2
SCHEMBL11458038 0.72 CYP19A1 (0.54) CYP2C19CYP2C9CYP1A2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 ALOX5AP 1154/4885FEN1 4291/4885CYP3A4 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.